Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Brad H Rovin; Dawn J Caster; Daniel C Cattran; Keisha L Gibson; Jonathan J Hogan; Marcus J Moeller; Dario Roccatello; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Jürgen Floege; Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Participants

doi:10.1016/j.kint.2018.11.008

Back

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Journal article

Open access

Peer reviewed

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Brad H Rovin, Dawn J Caster, Daniel C Cattran, Keisha L Gibson, Jonathan J Hogan, Marcus J Moeller, Dario Roccatello, Michael Cheung, David C Wheeler, Wolfgang C Winkelmayer, …

Kidney international, Vol.95(2), pp.281-295

02/2019

DOI: 10.1016/j.kint.2018.11.008

PMID: 30665569

Files and links (1)

url

https://doi.org/10.1016/j.kint.2018.11.008View

Published (Version of record) Open Access

Abstract

In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative brought a diverse panel of experts in glomerular diseases together to discuss the 2012 KDIGO glomerulonephritis guideline in the context of new developments and insights that had occurred over the years since its publication. During this KDIGO Controversies Conference on Glomerular Diseases, the group examined data on disease pathogenesis, biomarkers, and treatments to identify areas of consensus and areas of controversy. This report summarizes the discussions on primary podocytopathies, lupus nephritis, anti-neutrophil cytoplasmic antibody-associated nephritis, complement-mediated kidney diseases, and monoclonal gammopathies of renal significance.

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - diagnosis

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - genetics

Biomarkers - analysis

Consensus Development Conferences as Topic

Disease Progression

Genetic Testing

Glomerular Filtration Rate

Glomerulonephritis - etiology

Glomerulonephritis - pathology

Glomerulonephritis - therapy

Humans

Nephrology - methods

Nephrology - standards

Nephrosis, Lipoid - etiology

Nephrosis, Lipoid - pathology

Nephrosis, Lipoid - therapy

Paraproteinemias - complications

Paraproteinemias - diagnosis

Paraproteinemias - genetics

Podocytes - immunology

Podocytes - pathology

Practice Guidelines as Topic

Risk Factors

Treatment Outcome

Details

Title: Subtitle: Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Creators: Brad H Rovin - The Ohio State University Wexner Medical Center
Dawn J Caster - University of Louisville
Daniel C Cattran - University of Toronto
Keisha L Gibson - University of North Carolina at Chapel Hill
Jonathan J Hogan - University of Pennsylvania
Marcus J Moeller - Westfälische Hochschule
Dario Roccatello - University of Turin
Michael Cheung - KDIGO, Brussels, Belgium
David C Wheeler - University College London
Wolfgang C Winkelmayer - Baylor College of Medicine
Jürgen Floege - Westfälische Hochschule
Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Participants
Contributors: Carla M Nester (Contributor) - University of Iowa, Nephrology, Dialysis and Transplantation
Resource Type: Journal article
Publication Details: Kidney international, Vol.95(2), pp.281-295
DOI: 10.1016/j.kint.2018.11.008
PMID: 30665569
ISSN: 0085-2538
eISSN: 1523-1755
Grant note: 212252/Z/18/Z / Wellcome Trust
Language: English
Date published: 02/2019
Academic Unit: Nephrology, Dialysis and Transplantation; Stead Family Department of Pediatrics; Internal Medicine
Record Identifier: 9984353933502771

Metrics

7 Record Views

119 Times Cited - Web of Science

See more details